These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 197477)

  • 1. Hypo-hyperparathyroidism: evidence for a defective parathyroid hormone.
    Connors MH; Irias JJ; Golabi M
    Pediatrics; 1977 Sep; 60(3):343-8. PubMed ID: 197477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].
    Stögmann W
    Wien Klin Wochenschr Suppl; 1975; 33():1-15. PubMed ID: 176830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of hypocalcemia in primary hypomagnesemia: normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function.
    Suh SM; Tashjian AH; Matsuo N; Parkinson DK; Fraser D
    J Clin Invest; 1973 Jan; 52(1):153-60. PubMed ID: 4345201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic idiopathic hypoparathyroidism: report of 3 cases].
    Alvarez Aparicio E; Prieto Veiga J; Blázquez García J; de Manueles Jiménez J; Palomero Elorduy B; Herrera Criado F; Salazar Villalobos V
    An Esp Pediatr; 1985 Apr; 22(5):402-6. PubMed ID: 2990273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pseudo-idiopathic hypoparathyroidism].
    Playán Usón J; Sanz Paris A; Bosque Peralta MT; Trincado Aznar P; Acha Peréz J; Albero Gamboa R
    An Med Interna; 1996 Jun; 13(6):288-90. PubMed ID: 8962961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms.
    Brickman AS; Massry SG; Coburn JW
    J Clin Invest; 1972 Apr; 51(4):945-54. PubMed ID: 4552338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of hypoparathyroidism and pseudohypoparathyroidism.
    Lewin IG; Papapoulos SE; Tomlinson S; Hendy GN; O'Riordan JL
    Q J Med; 1978 Oct; 47(188):533-48. PubMed ID: 220660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone infusion test in children and adolescents.
    Hochberg Z; Moses AM; Richman RA
    Miner Electrolyte Metab; 1984; 10(2):113-6. PubMed ID: 6321936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols.
    Salusky IB; Goodman WG; Sahney S; Gales B; Perilloux A; Wang HJ; Elashoff RM; Jüppner H
    J Am Soc Nephrol; 2005 Aug; 16(8):2501-8. PubMed ID: 15944337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective deficiency of 1,25-dihydroxycholecalciferol. A cause of isolated skeletal resistance to parathyroid hormone.
    Metz SA; Baylink DJ; Hughes MR; Haussler MR; Robertson RP
    N Engl J Med; 1977 Nov; 297(20):1084-90. PubMed ID: 198661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic tests in parathyroid diseases].
    Burckhardt P
    Schweiz Med Wochenschr; 1986 Feb; 116(6):173-8. PubMed ID: 3006236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
    Lindberg J; Martin KJ; González EA; Acchiardo SR; Valdin JR; Soltanek C
    Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone changes during phosphorus load in patients with chronic renal insufficiency with low serum parathyroid hormone or adynamic bone disease.
    Cuppari L; Carvalho AB; Lobão RR; Martini LA; Cendoroglo M; Ventura RT; Draibe SA
    Clin Nephrol; 2001 Jul; 56(1):35-43. PubMed ID: 11499657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal-resistant hormonoplethoric hypoparathyroidism with evidence for a defective response to cAMP.
    Duck SC; Rosenberg EM; Ratzan SK; Haymond MW
    J Clin Endocrinol Metab; 1978 Sep; 47(3):640-6. PubMed ID: 233678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma immunoreactive N-terminal parathyroid hormone and cyclic AMP and cyclic GMP urinary levels in man after I. M. administration of two different doses of porcine calcitonin.
    Vigo PL; Milhaud G; Peracchi M; Girardello R; Ortolani S; Polli EE
    Biomedicine; 1980 Dec; 33(8):255-9. PubMed ID: 6260260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigations of the urinary cAMP-excretion in pseudohypoparathyroidism (author's transl)].
    Stögmann W
    Padiatr Padol Suppl; 1977; (5):63-9. PubMed ID: 199875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
    Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
    Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
    Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
    Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hypoparathyroidism in dogs: a retrospective study of 17 cases.
    Russell NJ; Bond KA; Robertson ID; Parry BW; Irwin PJ
    Aust Vet J; 2006 Aug; 84(8):285-90. PubMed ID: 16911229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.